April 10, 2024 - On more than 15,000 sqm in Dresden-Rossendorf, research and production facilities for the development of radiopharmaceutical innovations will be established in the future. The focus is on contract development and manufacturing services (CDMO) for clinical trials, as well as on commercial cGMP production of radiopharmaceutical drugs in the fields of cancer diagnostics and therapy.

December 23, 2023 - This year, we are therefore donating €10,000 to the Bundesverband Kinderhospiz e.V. We greatly appreciate your loyalty and collaboration, and we wish you and your families a joyful Christmas and a successful start to the coming year. The work of this association in support of seriously ill children and their families moves us deeply. As a pharmaceutical manufacturer in the field of nuclear medicine—especially in cancer diagnostics—we are acutely aware of our responsibility toward those who rely on help the most.

July 14, 2021 – Congratulations to Prof. (em.) Dr. Jörg Steinbach, Ms. Dorit Teichmann as transfer mediator, the Institute of Radiopharmaceutical Cancer Research at HZDR, and the entire ROTOP Radiopharmacy team for winning 1st place in the Transfer category. The award recognized the successful technology transfer for our joint project on GMP manufacturing of Iodine-123-labeled radiopharmaceuticals for Parkinson’s diagnostics.